Long-Term Outcomes of ThuLEP Reported for Benign Prostatic Enlargement
Rates of reinterventions low for persistence or regrowth of prostate adenoma, long-term complications.
Rates of reinterventions low for persistence or regrowth of prostate adenoma, long-term complications.
Rezūm therapy significantly improved symptoms, urinary flow, and quality of life in men across a wide range of prostate sizes, data show.
The procedure is now performed in one-third of all surgeries for benign prostatic hyperplasia, a study found.
Data on whether 5-ARIs increase the risk of prostate cancer-specific mortality have been mixed.
Prostatic artery embolization is a minimally invasive surgical technique that involves selective cannulation of the prostatic arteries.
The likelihood of conversion from HoLEP to an open procedure to treat benign prostatic hyperplasia increases along with prostate size.
Investigators found a significant positive correlation between transitional zone index (TZI) and IPSS and a significant negative correlation between TZI and both the International Index of Erectile Function and penile peak systolic velocity.
Complication and readmission rates for patients who undergo holmium laser enucleation of the prostate are similar whether patients are discharged directly from post-anesthesia care or are admitted to a hospital overnight, a study found.
Improved visualization of prostatic arteries shortens procedure time and decreases radiation exposure, new findings suggest.
Of patients who had transient stress urinary incontinence after holmium laser enucleation of the prostate, 88.6% experienced resolution of the incontinence within 6 weeks after the procedure.